Discovery of novel benzo[b][1,4]oxazin-3(4H)-ones as poly(ADP-ribose)polymerase inhibitors
Gangloff, A.R., Brown, J., de Jong, R., Dougan, D.R., Grimshaw, C.E., Hixon, M., Jennings, A., Kamran, R., Kiryanov, A., O'Connell, S., Taylor, E., Vu, P.(2013) Bioorg Med Chem Lett 23: 4501-4505
- PubMed: 23850199 
- DOI: https://doi.org/10.1016/j.bmcl.2013.06.055
- Primary Citation of Related Structures:  
4L6S - PubMed Abstract: 
Structure based drug design of a series of novel 1,4-benzoxazin-3-one derived PARP-1 inhibitors are described. The synthesis, enzymatic & cellular activities and pharmacodynamic effects are described. Optimized analogs demonstrated inhibition of poly-ADP-ribosylation in SW620 tumor bearing nude mice through 24h following a single dose.
Organizational Affiliation: 
Takeda California, 10410 Science Center Dr, San Diego, CA 92121, USA. anthony.gangloff@takeda.com